Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony F Shields

Showing results (71-80 of 186) with videos related to

Pageof 19
Sort By:
Journal of Gastrointestinal Cancer|January 5, 2024
Gastric Cancer Survivorship: Multidisciplinary Management, Best Practices and OpportunitiesEra Cobani, Mohammed Najeeb Al Hallak, Anthony F Shields, et al.
Pancreas|December 25, 2002
Clinicopathologic analysis of pancreatic adenocarcinoma in African Americans and CaucasiansNat L Pernick, Fazlul H Sarkar, Philip A Philip, et al.
Medical Oncology (Northwood, London, England)|October 24, 2009
Clinicopathological analysis of primary epithelial appendiceal neoplasmsSachin Gupta, Venkata Parsa, Volkan Adsay, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 17, 2009
PET and PET/CT reports: observations from the National Oncologic PET RegistryR Edward Coleman, Bruce E Hillner, Anthony F Shields, et al.
Cancer|July 13, 2012
Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy: a pooled analysis of 6 prospective trialsTodd M Bauer, Bassel F El-Rayes, Xiaobai Li, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2004
Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancerEdgar Ben-Josef, Anthony F Shields, Ulka Vaishampayan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 6, 2007
Tumor imaging using 1-(2'-deoxy-2'-18F-fluoro-beta-D-arabinofuranosyl)thymine and PETOmid S Tehrani, Otto Muzik, Lance K Heilbrun, et al.
Annals of Nuclear Medicine|February 28, 2019
The use of 3'-deoxy-3'-<sup>18</sup>F-fluorothymidine (FLT) PET in the assessment of long-term survival in breast cancer patients treated with neoadjuvant chemotherapyBenjamin E Ueberroth, Jawana M Lawhorn-Crews, Lance K Heilbrun, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 19, 2016
Effects of capecitabine treatment on the uptake of thymidine analogs using exploratory PET imaging agents: <sup>18</sup>F-FAU, <sup>18</sup>F-FMAU, and <sup>18</sup>F-FLTChristopher I McHugh, Jawana M Lawhorn-Crews, Dipenkumar Modi, et al.
European Journal of Cancer (Oxford, England : 1990)|September 6, 2020
A new prognostic and predictive tool for shared decision making in stage III colon cancerAlberto F Sobrero, Alberto Puccini, Qian Shi, et al.
Pageof 19

Showing results (71-80 of 186) with videos related to

Sort By:
Pageof 19
Journal of Gastrointestinal Cancer|January 5, 2024
Gastric Cancer Survivorship: Multidisciplinary Management, Best Practices and OpportunitiesEra Cobani, Mohammed Najeeb Al Hallak, Anthony F Shields, et al.
Pancreas|December 25, 2002
Clinicopathologic analysis of pancreatic adenocarcinoma in African Americans and CaucasiansNat L Pernick, Fazlul H Sarkar, Philip A Philip, et al.
Medical Oncology (Northwood, London, England)|October 24, 2009
Clinicopathological analysis of primary epithelial appendiceal neoplasmsSachin Gupta, Venkata Parsa, Volkan Adsay, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 17, 2009
PET and PET/CT reports: observations from the National Oncologic PET RegistryR Edward Coleman, Bruce E Hillner, Anthony F Shields, et al.
Cancer|July 13, 2012
Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy: a pooled analysis of 6 prospective trialsTodd M Bauer, Bassel F El-Rayes, Xiaobai Li, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2004
Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancerEdgar Ben-Josef, Anthony F Shields, Ulka Vaishampayan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 6, 2007
Tumor imaging using 1-(2'-deoxy-2'-18F-fluoro-beta-D-arabinofuranosyl)thymine and PETOmid S Tehrani, Otto Muzik, Lance K Heilbrun, et al.
Annals of Nuclear Medicine|February 28, 2019
The use of 3'-deoxy-3'-<sup>18</sup>F-fluorothymidine (FLT) PET in the assessment of long-term survival in breast cancer patients treated with neoadjuvant chemotherapyBenjamin E Ueberroth, Jawana M Lawhorn-Crews, Lance K Heilbrun, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 19, 2016
Effects of capecitabine treatment on the uptake of thymidine analogs using exploratory PET imaging agents: <sup>18</sup>F-FAU, <sup>18</sup>F-FMAU, and <sup>18</sup>F-FLTChristopher I McHugh, Jawana M Lawhorn-Crews, Dipenkumar Modi, et al.
European Journal of Cancer (Oxford, England : 1990)|September 6, 2020
A new prognostic and predictive tool for shared decision making in stage III colon cancerAlberto F Sobrero, Alberto Puccini, Qian Shi, et al.
Pageof 19